PRAX
Price
$60.48
Change
+$0.59 (+0.99%)
Updated
Sep 16, 10:46 AM (EDT)
51 days until earnings call
VERU
Price
$0.82
Change
-$0.01 (-1.20%)
Updated
Sep 16, 10:35 AM (EDT)
77 days until earnings call
Ad is loading...

PRAX vs VERU

Header iconPRAX vs VERU Comparison
Open Charts PRAX vs VERUBanner chart's image
Praxis Precision Medicines
Price$60.48
Change+$0.59 (+0.99%)
Volume$200
CapitalizationN/A
Veru
Price$0.82
Change-$0.01 (-1.20%)
Volume$400
CapitalizationN/A
View a ticker or compare two or three
PRAX vs VERU Comparison Chart
Loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PRAX vs. VERU commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRAX is a Hold and VERU is a StrongBuy.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (PRAX: $59.88 vs. VERU: $0.83)
Brand notoriety: PRAX and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRAX: 105% vs. VERU: 88%
Market capitalization -- PRAX: $1.06B vs. VERU: $120.93M
PRAX [@Biotechnology] is valued at $1.06B. VERU’s [@Biotechnology] market capitalization is $120.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRAX’s FA Score shows that 0 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • PRAX’s FA Score: 0 green, 5 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, both PRAX and VERU are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRAX’s TA Score shows that 3 TA indicator(s) are bullish while VERU’s TA Score has 4 bullish TA indicator(s).

  • PRAX’s TA Score: 3 bullish, 5 bearish.
  • VERU’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VERU is a better buy in the short-term than PRAX.

Price Growth

PRAX (@Biotechnology) experienced а +10.85% price change this week, while VERU (@Biotechnology) price change was -2.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.48%. For the same industry, the average monthly price growth was +4.66%, and the average quarterly price growth was -1.61%.

Reported Earning Dates

PRAX is expected to report earnings on Nov 06, 2024.

VERU is expected to report earnings on Dec 02, 2024.

Industries' Descriptions

@Biotechnology (+2.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($1.06B) has a higher market cap than VERU($121M). PRAX YTD gains are higher at: 168.761 vs. VERU (14.736). VERU has higher annual earnings (EBITDA): -35.59M vs. PRAX (-132.26M). PRAX has more cash in the bank: 352M vs. VERU (29.2M). PRAX has less debt than VERU: PRAX (1.95M) vs VERU (13.7M). VERU has higher revenues than PRAX: VERU (14.1M) vs PRAX (1.77M).
PRAXVERUPRAX / VERU
Capitalization1.06B121M879%
EBITDA-132.26M-35.59M372%
Gain YTD168.76114.7361,145%
P/E RatioN/AN/A-
Revenue1.77M14.1M13%
Total Cash352M29.2M1,205%
Total Debt1.95M13.7M14%
FUNDAMENTALS RATINGS
VERU: Fundamental Ratings
VERU
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRAXVERU
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IQST0.190.01
+4.46%
iQSTEL Inc.
GEBHY5.050.19
+3.87%
Genting Berhad
ARZGY13.860.10
+0.76%
Assicurazioni Generali Spa
GICUX13.560.08
+0.59%
Goldman Sachs Intl Sm Cp Insghts R6
SKHSY26.81-0.23
-0.85%
Sekisui House Ltd.